Altered extent, pattern and characteristics of microvascular density are indicators of neoplastic progression in the endometrium

International Journal of Cancer

Volumn 115, Issue 6, 2005, Pages 975-980

  Näyhä, Veera ^a   Viitanen, Tea ^a   Stenbäck, Frej ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Endometrial hyperplasia; Endometrial tumors; Endometrium; Microvascular density; Morphometry

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; DISEASE COURSE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALIGNANT NEOPLASTIC DISEASE; MICROVASCULATURE; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PRECANCEROUS CONDITIONS;

EID: 20444430126     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20930     Document Type: Article

References (59)

1. Folkman J. Angiogenesis-dependent diseases. Semin Oncol 2001;28:536-42.
2. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML. Yeo TK, Tognazzi K, Dvorak HF. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-56.
3. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;14:249-57.
4. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
5. Bancher-Todesca D, Obermair A, Bilgi S, Kohlberger P, Kainz C, Breitenecker G, Leodolter S, Gitsch G. Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol 1997;64:496-500.
6. Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, Brown LF. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995;7:1237-45.
7. Gasparini G, Bonoldi E, Viale G, Verderio P, Boracchi P, Panizzoni GA, Radaelli U, Di Bacco A, Guglielmi RB, Bevilacqua P. Prognostic and predictive value of tumour andogenesis in ovarian carcinomas. Int J Cancer 1996;69:205-11.
8. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 1993;10:302-13.
9. Weidner N. Angiogenesis as a predictor of clinical outcome in cancer patients. Hum Pathol 2000;31:403-5.
10. Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, Isola JJ. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol 1995;8:745-52.
11. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002;19;94:883-93.
12. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4.
13. Smith SK. Angiogenesis and reproduction. BJOG 2001;108:777-83.
14. Gargett CE, Rogers PA. Human endometrial angiogenesis Reproduction 2001;121:181-6.
15. Rogers PA, Lederman F, Taylor N. Endometrial microvascular growth in normal and dysfunctional states Hum Reprod Update 1998;4:503-8.
16. Rogers PA, Au CL, Affandi B. Endometrial microvascular density during the normal menstrual cycle and following exposure to long time levonorgestrel Hum Reprod 1993;8:1396-1404.
17. Johannissson E, Landgren BM, Diczfalusy E. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 μg norethisterone (NET) minipill. Contraception 1982;25:13-30.
18. Peek M, Landgren BM, Johannisson E. The endometrial capillaries durine the normal menstrual cycle: a morphometric study. Hum Reprod 1992;7:906-11.
19. Taylor RN, Lebovic DI, Hornung D, Mueller MD. Endocrine and paracrine regulation of endometrial angiogenesis. Ann NY Acad Sci 2001;943:109-121.
20. Abulafia O, Triest WE, Sherer DM, Hansen CC, Ghezzi F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol 1995;86:479-85.
21. Abulafia O, Sherer DM. Angiogenesis of the endometrium. Obstet Gynecol 1999;94:148-53.
22. Kirschner CV, Alanis-Amezcua JM, Martin VG, Luna N, Morgan E, Yang JJ, Yordan EL. Angiogenesis factor in endometrial carcinoma: a new prognostic indicator? Am J Obstet Gynecol 1996;174:1879-82.
23. Wagatsuma S, Konno R, Sato S, Yajima A. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 1998;82:520-30.
24. Giatromanolaki A, Sivridis E, Koukourakis MI, Georgoulias V, Gatter KC, Harris AL. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas? Oncol Res 1999;11:205-12.
25. Kaku T, Kamura T, Kinukawa N, Kobayashi H, Sakai K, Tsuruchi N, Saito T, Kawauchi S, Tsuneyoshi M, Nakano H. Angiogenesis in endometrial carcinoma. Cancer 1997;80:741-7.
26. Kaku T, Kamura T, Hirakawa T, Sakai K, Amada S, Kobayashi H, Nakano H. Endometrial carcinoma associated with hyperplasia-immunohistochemical study of angiogenesis and p53 expression. Gynecol Oncol 1999;72:51-5.
27. Obermair A, Tempfer C, Wasicky R, Kaider A, Heller L, Kainz C. Prognostic significance of tumor angiogenesis in endometrial cancer. Obstet Gynecol 1999;93:367-71.
28. Morgan KG, Wilkinson N, Buckley CH. Angiogenesis in normal, hyperplastic, and neoplastic endometrium. J Pathol 1996;179:317-20.
29. Gambino LS, Wreford NG, Bertram JF, Dockery P, Lederman F, Rogers PA. Angiogenesis occurs by vessel elongation in proliferative phase human endometrium. Hum Reprod 2002;17:1199-206.
30. Baak JPA. The role of computerized morphometric and cytometric feature analysis in endometrial hyperplasia and cancer prognosis. J Cell Biochem 1995;59(Suppl 23):137-46.
31. Mutter GL, Baak JPA Crum CP, Richart RM, Ferenczy A, Faquin WC. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol 2000;190:462-9.
32. Näyhä V, Laitakari J, Stenbäck F. Stage-dependent expression of an angiogenic agent and vascular organization in experimental skin tumor development. Toxicol Pathol 2003;31:539-48.
33. Ronnett BM, Kurman RJ. Precursor lesions of endometrial carcinoma. In: Kurman RJ, ed. Blaustein's pathology of female genital tract. 5th ed. New York: Springer-Verlag, 2002.467-500.
34. Ronnett BM, Zaino RJ, Ellenson LH, Kurman RJ. Endometrial cancer. In: Kurman RJ, ed. Blaustein's pathology of female genital tract, 5th ed. New York: Springer-Verlag, 2002.501-60.
35. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 2000;80:99-115.
36. Gargett CE, Lederman F, Heryanto B, Gambino LS, Rogers PA. Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils. Hum Reprod 2001;16:1065-75.
37. Ono M, Shiina Y. Cytological evaluation of angiogenesis in endometrial aspirates. Cytopathology 2001;12:37-43.
38. Horbelt DV, Roberts DK, Parmley TH, Walker NJ. Ultrastructure of the microvasculature in human endometrial hyperplasia. Am J Obstet Gynecol 1996;174:174-83.
39. Burri PH, Tarek MR. A novel mechanism of capillary growth in the rat pulmonary microcirculation. Anat Rec 1990;228:35-45.
40. Dockery P, Perret S, Rogers PAW, Bulut EH, Reu B, Warren MA, Li T-C, Harvey BJ, Jenkins D, Cooke ID. Endometrial morphology and the endometrial vascular bed. In: O'Brian S, Cameron I, MacLean A, eds. Disorders of the menstrual cycle. London: RCOG Press, 2000. 402 p.
41. Keith RL, Miller YE, Gemmill RM, Drabkin HA, Dempsey EC, Kennedy TC, Prindiville S, Franklin WA. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res 2000;6:1616-25.
42. Salvesen HB, Iversen OE, Akslen LA. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study. J Clin Oncol 1999;17:1382-90.
43. Fujisawa T, Watanabe J, Akaboshi M, Ohno E, Kuramoto H. Immunohistochemical study on VEGF expression in endometrial carcinoma-comparison with p53 expression, angiogenesis, and tumor histologic grade. J Cancer Res Clin Oncol 2001;127:668-74.
44. Sivridis E. Angiogenesis and endometrial cancer. Anticancer Res 2001;21:4383-8.
45. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7:82-90.
46. Laitakari J, Harrison D, Stenbäck F. Morphometrical characteristics of cell proliferation and p53 expression in development of experimentally induced respiratory tumors. Analyt Quant Cytol Histol 2001;23:273-86.
47. Laitakari J, Näyhä V. Stenbäck F. Size, shape, structure, and direction of angiogenesis in laryngeal tumour development. J Clin Pathol 2004;57:394-401.
48. Kohlberger PD, Obermair A, Sliutz G, Heinzl H, Koelbl H, Breitenecker G, Gitsch G, Kainz C. Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. Am J Clin Pathol 1996;105:705-10.
49. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002;38:1564-79.
50. Offersen BV, Borre M, Overgaard J. Quantification of angiogenesis as a prognostic marker in human carcinomas. A critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 2003;39:881-90.
51. Boyle J. Histological measurement of tumour angiogenesis. Eur J Cancer 2003;39:859-60.
52. Thompson WD, Li WW, Maragoudakis M. The clinical manipulation of angiogenesis: pathology side-effects, surprises and opportunities with novel human therapies. J Pathol 2000;190:330-7.
53. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
54. Jikihara H, Terada N, Yamamoto R, Nishikawa Y, Tanizawa O, Matsumoto K, Terakawa N. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer. Am J Obstet Gynecol 1992;167:207-11.
55. Fujimoto J, Hosoda S, Fujita H, Okada H. Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invas Metastasis 1989;9:269-77.
56. Abulafia O, Triest WE, Adcock JT, Sheerer DM. The effect of medroxyprogesterone acetate on angiogenesis in complex endometrial hyperplasia. Gynecol Oncol 1999;72:193-8.
57. Wahab M, Thompson J, Al-Azzawi F. Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle. A morphometric analysis. Hum Reprod 2000;15:2075-81.
58. Hourihan HM, Sheppard BL, Bonnar J. A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels. Contraception 1986;34:603-12.
59. Hourihan HM, Sheppard BL, Belsey EM, Brosens IA. Endometrial vascular features prior to and following exposure to levonorgestrel. Contraception 1991;43:375-85.